Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $192.68 million.

GUIDANCE:

Repligen sees FY2022 EPS of $3.15-$3.20, versus the consensus of $3.20. Repligen sees FY2022 revenue of $795-805 million, versus the consensus of $804 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy
• Barclays Downgrades Equity LifeStyle Properties (ELS) to Equalweight